Ownership Summary
Adicet Bio, Inc. (NASDAQ:ACET) has 1 institutional investors that have filed 13F reports for the period ending December 2025.
- These investors held 1.1% of outstanding shares in December 2025, down from 56.3% in September 2025.
- Their total shares held in ACET decreased -0.0% quarter over quarter, and separately, investors owning Adicet Bio decreased 98.46% from a year ago.
- Activity in ACET broke down as 0 buyers, 1 sellers, and 0 unchanged among 1 total holders.
- The aggregate institutional position in Adicet Bio amounted to 60.51K shares as of December 2025, down by 0 shares quarter on quarter, and down 3.55Mn shares year over year.
- Regeneron Pharmaceuticals, Inc. is the top holder of Adicet Bio as of December 31, 2025, with 60.51K shares representing 1.06% of outstanding stock.
- The largest sales of ACET for the quarter ending December 2025 came from Regeneron Pharmaceuticals, Inc. (0).
- Per Business Quant, the top 1 investors in ACET for the quarter ending December 2025 include Regeneron Pharmaceuticals, Inc. (60.51K).